M&T Bank Corporation
—Price / book
Market cap
—
Tangible equity
$20.65B
Price / tangible book
—
Price / book
—
Return on equity
9.8%
Return on assets
1.3%
Efficiency ratio
41.5%
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2025 · Mkt capMarket cap $138.42B · View financials
Decision snapshot: MTB stock price vs VRTX: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at VRTX's multiple
Needs VRTX P/E.
Implied fair value · at MTB's multiple
Needs MTB P/E.
Snapshot Sep 4, 4:00 PM ET
Metric by metric
Filter, sort, and scan the equity metrics that matter most for banks: book value, tangible book, returns, and operating efficiency.
Lower is better
Lower is better
Profitability lag
Asset efficiency lag
Lower is better
Statements
Bank-focused income statement and equity metrics aligned to the reporting windows.
SEC periods: MTB FY 2025 (ended Dec 31, 2025) · VRTX FY 2025 (ended Dec 31, 2025).
Trendline
Five fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Tangible book and profitability anchor a bank, not enterprise value.
Deposits and cash-like balances distort enterprise value for banks, so this section reads equity value, tangible book and profitability instead.
Price / book
Market cap
—
Tangible equity
$20.65B
Price / tangible book
—
Price / book
—
Return on equity
9.8%
Return on assets
1.3%
Efficiency ratio
41.5%
Price / tangible book
Market cap
$138.42B
Tangible equity
$17.15B
Price / tangible book
8.07x
Price / book
7.42x
Return on equity
21.2%
Return on assets
15.4%
Efficiency ratio
—
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
M&T BANK CORPORATION · implied price per share
Bank model off — standard DCF modelling is disabled for financial institutions.
VERTEX PHARMACEUTICALS INC / MA · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Debt / equity
Total debt against shareholders' equity
0.45x
0.23x
Net debt / EBITDA
Leverage against operating earnings
—
-0.49x
Cash and equivalents
Liquid reserves on the balance sheet
—
$6.61B
Total debt
Interest-bearing obligations outstanding
$13.06B
$4.23B
Comparable set
Where the pair sits against the wider banking comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
JPMorgan Chase & Co.
MTB vs JPM
Bank of America Corporation
MTB vs BAC
Wells Fargo & Company
MTB vs WFC
Citigroup Inc.
MTB vs C
PNC FINANCIAL SERVICES GROUP, INC.
MTB vs PNC
AMGEN INC
MTB vs AMGN
Gilead Sciences, Inc.
MTB vs GILD
BIOGEN INC.
MTB vs BIIB
Moderna, Inc.
MTB vs MRNA
Illumina, Inc.
MTB vs ILMN
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.